|
|
Volumn 88, Issue 8, 2009, Pages 508-510
|
|
Local botulinum neurotoxin A therapy in tardive lingual dyskinesia;Lokale botulinumneurotoxin-A-therapie bei tardiver dyskinesie der zunge
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ARIPIPRAZOLE;
BENZODIAZEPINE DERIVATIVE;
BOTULINUM TOXIN A;
CLONAZEPAM;
DIAZEPAM;
FLUPENTIXOL;
LORAZEPAM;
NEUROLEPTIC AGENT;
OLANZAPINE;
PSYCHOTROPIC AGENT;
QUETIAPINE;
ZIPRASIDONE;
ABSENCE OF SIDE EFFECTS;
ADULT;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
DISEASE COURSE;
DRUG EFFICACY;
DRUG WITHDRAWAL;
HUMAN;
MALE;
MUSCLE;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
TARDIVE DYSKINESIA;
TARDIVE LINGUAL DYSKINESIA;
TONGUE DISEASE;
TREATMENT DURATION;
TREATMENT FAILURE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADULT;
ANTIPSYCHOTIC AGENTS;
BOTULINUM TOXIN TYPE A;
DRUG ADMINISTRATION SCHEDULE;
DYSKINESIA, DRUG-INDUCED;
ELECTROMYOGRAPHY;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
MALE;
NEUROMUSCULAR AGENTS;
RECURRENCE;
RETREATMENT;
SPEECH INTELLIGIBILITY;
TONGUE DISEASES;
ULTRASONOGRAPHY, INTERVENTIONAL;
|
|
EID: 70049094245
PISSN: 09358943
EISSN: 14388685
Source Type: Journal
DOI: 10.1055/s-0029-1233272 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
